Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Neubauer

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancer Treatment and Research Communications|January 30, 2022
Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in GermanyM P Lux, C Minartz, H Müller-Huesmann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 26, 2012
[Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema]M Kernt, R Cheuteu, R G Liegl, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 8, 2010
[Comparison of superselective intraarterial fibrinolysis with conservative therapy. Use in patients with acute non-arteritic central retinal artery occlusion]A Wolf, M Schumacher, A S Neubauer, et al.
Growth Factors (Chur, Switzerland)|February 20, 2010
Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factorM Kernt, R G Liegl, J Rueping, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 17, 2009
[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]M Kernt, C Hirneiss, A S Neubauer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium]M Kernt, S Thiele, C Hirneiss, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancer Treatment and Research Communications|January 30, 2022
Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in GermanyM P Lux, C Minartz, H Müller-Huesmann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 26, 2012
[Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema]M Kernt, R Cheuteu, R G Liegl, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 8, 2010
[Comparison of superselective intraarterial fibrinolysis with conservative therapy. Use in patients with acute non-arteritic central retinal artery occlusion]A Wolf, M Schumacher, A S Neubauer, et al.
Growth Factors (Chur, Switzerland)|February 20, 2010
Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factorM Kernt, R G Liegl, J Rueping, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 17, 2009
[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]M Kernt, C Hirneiss, A S Neubauer, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium]M Kernt, S Thiele, C Hirneiss, et al.
Pageof 6